Literature DB >> 1696946

DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels.

P Waring1.   

Abstract

We have shown that the immunomodulating agent gliotoxin induces DNA fragmentation in macrophages characteristic of programmed cell death or apoptosis (Waring, P., Eichner, R. D., Mullbacher, A., and Sjaarda, A. (1988) J. Biol. Chem, 263, 18493-18499). In addition, morphological changes and DNA fragmentation characteristic of apoptosis are induced in 48 h concanavalin A-stimulated T blasts by gliotoxin and these changes are inhibited by Zn2+ (Waring, P., Egan, M., Braithwaite, A., Mullbacher, A., and Sjaarda, A. (1990) Int. J. Immunopharmacol., in press). We have studied the effects of actinomycin D and the protein synthesis inhibitor cycloheximide on apoptosis induced by gliotoxin in these cells, and these studies demonstrate no effect on apoptosis induced by gliotoxin. Cycloheximide and actinomycin D alone induce DNA fragmentation in these cells. Gliotoxin itself proved to be a potent inhibitor of protein synthesis. The fragmentation caused by cycloheximide correlated with the extent of protein synthesis inhibition. The toxin ricin also induced DNA fragmentation in T blasts characteristic of apoptosis. These results indicate that protein synthesis is not required for induction of apoptosis in macrophages or T blasts by gliotoxin. Gliotoxin caused elevated levels of inositol triphosphate in treated macrophages which may be related to mobilization of Ca2+ levels during apoptosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696946

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Rapid induction of apoptosis in rat liver by cycloheximide.

Authors:  G M Ledda-Columbano; P Coni; G Faa; G Manenti; A Columbano
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

2.  Culture filtrates of Aspergillus fumigatus induce different modes of cell death in human cancer cell lines.

Authors:  P Daly; S Verhaegen; M Clynes; K Kavanagh
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A).

Authors:  L Barbieri; P Valbonesi; E Bonora; P Gorini; A Bolognesi; F Stirpe
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

Review 4.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

5.  Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.

Authors:  K Sandvig; O Garred; A van Helvoort; G van Meer; B van Deurs
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

6.  Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation.

Authors:  Z Han; D Chatterjee; D M He; J Early; P Pantazis; J H Wyche; E A Hendrickson
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

Review 7.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

8.  Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2.

Authors:  D L Vaux; I L Weissman
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

9.  Induction of apoptosis by c-Fos protein.

Authors:  G A Preston; T T Lyon; Y Yin; J E Lang; G Solomon; L Annab; D G Srinivasan; D A Alcorta; J C Barrett
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

Review 10.  Toward an understanding of the molecular mechanisms of physiological cell death.

Authors:  D L Vaux
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.